medikinet xl 40mg toimeainet modifitseeritult vabastav kõvakapsel
medice arzneimittel puetter gmbh & co. kg - metüülfenidaat - toimeainet modifitseeritult vabastav kõvakapsel - 40mg 30tk; 40mg 50tk
medikinet xl 5mg toimeainet modifitseeritult vabastav kõvakapsel
medice arzneimittel puetter gmbh & co. kg - metüülfenidaat - toimeainet modifitseeritult vabastav kõvakapsel - 5mg 28tk; 5mg 30tk; 5mg 50tk
medikinet xl 10mg toimeainet modifitseeritult vabastav kõvakapsel
medice arzneimittel puetter gmbh & co. kg - metüülfenidaat - toimeainet modifitseeritult vabastav kõvakapsel - 10mg 50tk; 10mg 30tk
xorafia õhukese polümeerikattega tablett
lv system service sia - sorafeniib - õhukese polümeerikattega tablett - 200mg 112tk
suphrex kõvakapsel
lv system service sia - sunitiniib - kõvakapsel - 12,5mg 30tk
suphrex kõvakapsel
lv system service sia - sunitiniib - kõvakapsel - 50mg 30tk; 50mg 28tk
attentin tablett
medice arzneimittel puetter gmbh & co. kg - deksamfetamiin - tablett - 10mg 30tk
nucala
glaxosmithkline trading services - mepolizumab - astma - ravimid hingamisteede obstruktiivsete haiguste, - severe eosinophilic asthmanucala is indicated as an add-on treatment for severe refractory eosinophilic asthma in adults, adolescents and children aged 6 years and older. chronic rhinosinusitis with nasal polyps (crswnp)nucala is indicated as an add-on therapy with intranasal corticosteroids for the treatment of adult patients with severe crswnp for whom therapy with systemic corticosteroids and/or surgery do not provide adequate control. eosinophilic granulomatosis with polyangiitis (egpa)nucala is indicated as an add-on treatment for patients aged 6 years and older with relapsing-remitting or refractory eosinophilic granulomatosis with polyangiitis (egpa). hypereosinophilic syndrome (hes)nucala is indicated as an add-on treatment for adult patients with inadequately controlled hypereosinophilic syndrome without an identifiable non-haematologic secondary cause.
rolufta ellipta (previously rolufta)
glaxosmithkline trading services limited - umeklidiiniumbromiid - kopsuhaigus, krooniline obstruktiivne - ravimid hingamisteede obstruktiivsete haiguste, - rolufta on näidustatud kroonilise obstruktiivse kopsuhaiguse (kok) täiskasvanud patsientide sümptomite leevendamiseks bronhodilataatorite hoolduseks.